EPAM
IDXX icon

Evelyn Partners Asset Management’s Idexx Laboratories IDXX Stock Holding History

Evelyn Partners Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.87K Hold
14
– – ﹤0.01% 270
2025
Q4 		$9.47K Hold
14
– – ﹤0.01% 240
2025
Q3 		$8.94K Hold
14
– – ﹤0.01% 237
2025
Q2 		$7.51K Hold
14
– – ﹤0.01% 203
2025
Q1 		$5.88K Hold
14
– – ﹤0.01% 218
2024
Q4 		$5.79K Buy
+14
New +$6.14K ﹤0.01% 216

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evelyn Partners Asset Management's IDXX Position: Q1 2026 in Review

Evelyn Partners Asset Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 14 shares worth $7.87K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Evelyn Partners Asset Management first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.47K in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Evelyn Partners Asset Management held 14 shares of Idexx Laboratories worth $7.87K as of Q1 2026.
  • Evelyn Partners Asset Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #270 holding.
  • Evelyn Partners Asset Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Idexx Laboratories position peaked at $9.47K in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.